Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Neurochemical and behavioral responses to inflammatory immune stressors.

Gibb J, Audet MC, Hayley S, Anisman H.

Front Biosci (Schol Ed). 2009 Jun 1;1:275-95. Review.

PMID:
19482702
2.

[Brain-immune interactions and implications in psychiatric disorders].

Marques AH, Cizza G, Sternberg E.

Rev Bras Psiquiatr. 2007 May;29 Suppl 1:S27-32. Review. Portuguese.

3.

Cytokines, stress and depressive illness: brain-immune interactions.

Anisman H, Merali Z.

Ann Med. 2003;35(1):2-11. Review.

PMID:
12693607
4.

Cytokines as a precipitant of depressive illness: animal and human studies.

Anisman H, Merali Z, Poulter MO, Hayley S.

Curr Pharm Des. 2005;11(8):963-72. Review.

PMID:
15777247
5.

Cytokines as mediators of depression: what can we learn from animal studies?

Dunn AJ, Swiergiel AH, de Beaurepaire R.

Neurosci Biobehav Rev. 2005;29(4-5):891-909. Review.

PMID:
15885777
6.

Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis.

Simmons DA, Broderick PA.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):793-807. Review.

PMID:
15923072
7.

[The role of cytokines in depression].

Dubas-Slemp H, Marmurowska-Michałowska H, Szuster-Ciesielska A, Kamińska T, Kandefer-Szerszeń M.

Psychiatr Pol. 2003 Sep-Oct;37(5):787-98. Review. Polish.

PMID:
14631599
8.

Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes.

Anisman H, Kokkinidis L, Merali Z.

Brain Behav Immun. 2002 Oct;16(5):544-56. Review.

PMID:
12401468
9.

Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.

Anisman H, Merali Z, Hayley S.

Prog Neurobiol. 2008 May;85(1):1-74. doi: 10.1016/j.pneurobio.2008.01.004. Epub 2008 Feb 13. Review.

PMID:
18346832
10.

The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.

Hayley S, Poulter MO, Merali Z, Anisman H.

Neuroscience. 2005;135(3):659-78. Epub 2005 Sep 8. Review.

PMID:
16154288
11.
12.

Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.

Gold SM, Irwin MR.

Neurol Clin. 2006 Aug;24(3):507-19.

PMID:
16877121
13.

Illness, cytokines, and depression.

Yirmiya R, Pollak Y, Morag M, Reichenberg A, Barak O, Avitsur R, Shavit Y, Ovadia H, Weidenfeld J, Morag A, Newman ME, Pollmächer T.

Ann N Y Acad Sci. 2000;917:478-87.

PMID:
11268375
14.

The immune system, depression and the action of antidepressants.

Leonard BE.

Prog Neuropsychopharmacol Biol Psychiatry. 2001 May;25(4):767-80. Review.

PMID:
11383977
15.

Influence of chronic interleukin-2 infusion and stressors on sickness behaviors and neurochemical change in mice.

Sudom K, Turrin NP, Hayley S, Anisman H.

Neuroimmunomodulation. 2004;11(5):341-50.

PMID:
15316245
16.

The hygiene hypothesis and psychiatric disorders.

Rook GA, Lowry CA.

Trends Immunol. 2008 Apr;29(4):150-8. doi: 10.1016/j.it.2008.01.002. Epub 2008 Mar 6.

PMID:
18328783
17.

Cytokines and depression: an analogic approach.

Corcos M, Guilbaud O, Hjalmarsson L, Chambry J, Jeammet P.

Biomed Pharmacother. 2002 Mar;56(2):105-10. Review.

PMID:
12000135
18.

Effects of antidepressants on cytokine production and actions.

Castanon N, Leonard BE, Neveu PJ, Yirmiya R.

Brain Behav Immun. 2002 Oct;16(5):569-74. Review.

PMID:
12401470
19.
20.

Cytokines and major depression.

Schiepers OJ, Wichers MC, Maes M.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):201-17. Epub 2005 Jan 25. Review. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2005 May;29(4):637-8.

PMID:
15694227

Supplemental Content

Support Center